ASEAN Pharmaceutical Manufacturing 麻豆原创 2017-2027 by Formulation and Country: Trend Forecast and Growth Opportunity

Publication ID:

GRM0321041

Publication Date:

March 30, 2021

Pages:

Publisher:

Grace 麻豆原创 Data

Countries:

ASEAN [1]

USD 2,000.00

Pharmaceutical Manufacturing [2]

Pharma & Healthcare [3]

Description:

ASEAN pharmaceutical manufacturing industry will grow by 12.8% annually with a total addressable market cap of $148.3 billion over 2021-2027 driven by increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic.
Highlighted with 25 tables and 39 figures, this 66-page report 鈥淎SEAN Pharmaceutical Manufacturing 麻豆原创 2017-2027 by Formulation and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire ASEAN pharmaceutical manufacturing industry and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� Industry Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & Industry Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of ASEAN industry is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify ASEAN pharmaceutical manufacturing industry in every aspect of the classification from perspectives of Formulation and Country.

Based on Formulation, the ASEAN industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
鈥� Tablets
鈥� Capsules
鈥� Injectable
鈥� Sprays
鈥� Suspensions
鈥� Powders
鈥� Other Formulations

Geographically, the following national/local markets are fully investigated:
鈥� Indonesia
鈥� Thailand
鈥� Philippines
鈥� Vietnam
鈥� Singapore
鈥� Malaysia
鈥� Myanmar
鈥� Cambodia
鈥� Laos
鈥� Brunei
For each key country, detailed analysis and data for annual production value are available for 2017-2027. The breakdown of key national industry by Formulation and Manufacturer is also included.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

Table of Contents
1 Introduction 5
1.1 Industry Definition and Research Scope 5
1.1.1 Industry Definition 5
1.1.2 Research Scope 6
1.2 Research Methodology 8
1.2.1 Overview of 麻豆原创 Research Methodology 8
1.2.2 麻豆原创 Assumption 9
1.2.3 Secondary Data 9
1.2.4 Primary Data 9
1.2.5 Data Filtration and Model Design 11
1.2.6 麻豆原创 Size/Share Estimation 12
1.2.7 Research Limitations 13
1.3 Executive Summary 14
2 麻豆原创 Overview and Dynamics 16
2.1 麻豆原创 Size and Forecast 16
2.1.1 Impact of COVID-19 on World Economy 17
2.1.2 Impact of COVID-19 on the 麻豆原创 20
2.2 Major Growth Drivers 22
2.3 麻豆原创 Restraints and Challenges 25
2.4 Emerging Opportunities and 麻豆原创 Trends 28
2.5 Porter鈥檚 Fiver Forces Analysis 32
3 Segmentation of ASEAN 麻豆原创 by Formulation 36
3.1 麻豆原创 Overview by Formulation 36
3.2 Tablets 38
3.3 Capsules 39
3.4 Injectable 40
3.5 Sprays 41
3.6 Other Formulations 42
4 ASEAN 麻豆原创 2020-2027 by Country 43
4.1 Overview of ASEAN 麻豆原创 43
4.2 Indonesia 46
4.3 Thailand 48
4.4 Philippines 50
4.5 Vietnam 52
4.6 Singapore 54
4.7 Malaysia 56
4.8 Myanmar 58
4.9 Cambodia 60
4.10 Laos 62
4.11 Brunei 64
Related Reports and Products 66

Companies Mentioned:

No company profiles provided in this report

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.